Recently, Kim et al. also demonstrated that FGF21 combined with glucagon-like peptide-1 analogue could strongly ameliorate atherosclerosis-related process induced by T2DM in a mice model (65). The gene discussed is FGF21; the disease is type 2 diabetes mellitus.